Skip to main content
Lawrence Leung, MD, Oncology, Stanford, CA

Lawrence L Leung MD


Maureen Lyles D'Ambrogio Professor of Medicine - Hematology, Stanford University Medical Center; Chief of Staff, VA Palo Alto Health Care System

Join to View Full Profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Dr. Leung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1978 - 1982
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1975 - 1978
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Elected Member The American Society for Clinical Investigation, 1987

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Pulling Back the Curtain: Roy Silverstein, MD
    Pulling Back the Curtain: Roy Silverstein, MDDecember 1st, 2019
  • Predicting AAA Risk Using a Patient's Genome
    Predicting AAA Risk Using a Patient's GenomeSeptember 6th, 2018

Grant Support

  • Monoclonal antibody inhibition of thrombin cleavage of osteopontin as a novel therapeutic to enhance host antitumor immunity and reduce cardiac fibrosisVETERANS ADMIN PALO ALTO HEALTH CARE SYS2024–2028
  • Cross-Talk Between Coagulation, Inflammation, And ImmunityNational Heart, Lung, And Blood Institute2011–2012
  • Cross-Talk Between Coagulation, Inflammation, And ImmunityNational Heart, Lung, And Blood Institute2010
  • Functional Mapping And Protein Engineering Of ThrombinNational Heart, Lung, And Blood Institute1999–2007
  • Training Program In Investigative HematologyNational Heart, Lung, And Blood Institute2001–2003
  • Novel Inhibitors Of ThrombinNational Heart, Lung, And Blood Institute1993–1994
  • Molecular And Cellular Biology Of Glycoprotein IIIBNational Heart, Lung, And Blood Institute1989–1993
  • Histidine-Rich Glycoprotein: Cellular And Molecular BiolNational Heart, Lung, And Blood Institute1986
  • Platelet And Endothelial Cell Membrane GlycoproteinsNational Heart, Lung, And Blood Institute1985

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: